US Stock MarketDetailed Quotes
SKIN The Beauty Health
- 1.480
- +0.010+0.68%
Close Nov 29 13:00 ET
- 1.480
- 0.0000.00%
Post 17:01 ET
183.70MMarket Cap-3794P/E (TTM)
1.505High1.465Low273.50KVolume1.500Open1.470Pre Close408.60KTurnover0.34%Turnover RatioLossP/E (Static)124.12MShares5.17052wk High3.08P/B119.39MFloat Cap0.91052wk Low--Dividend TTM80.67MShs Float30.173Historical High--Div YieldTTM2.72%Amplitude0.910Historical Low1.493Avg Price1Lot Size
The Beauty Health Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -19.11%78.8M | -22.88%90.59M | -5.65%81.4M | 8.78%397.99M | -1.34%96.82M | 9.71%97.41M | 13.47%117.48M | 14.40%86.28M | 40.68%365.88M | 25.99%98.13M |
| Operating revenue | -19.11%78.8M | -22.88%90.59M | -5.65%81.4M | 8.78%397.99M | -1.34%96.82M | 9.71%97.41M | 13.47%117.48M | 14.40%86.28M | 40.68%365.88M | 25.99%98.13M |
| Cost of revenue | -65.30%38.15M | 0.10%49.65M | 2.70%33.04M | 107.42%242.88M | 61.60%51.14M | 300.91%109.97M | 48.09%49.6M | 31.16%32.17M | 43.59%117.1M | 29.59%31.64M |
| Gross profit | 423.82%40.65M | -39.68%40.94M | -10.61%48.36M | -37.65%155.11M | -31.29%45.69M | -120.46%-12.55M | -3.09%67.88M | 6.33%54.1M | 39.34%248.78M | 24.35%66.49M |
| Operating expense | -10.62%62.16M | -22.18%63.05M | -8.49%65.35M | 4.15%286.03M | -7.10%64.05M | 5.83%69.55M | 7.93%81.02M | 10.04%71.41M | 25.70%274.62M | 7.76%68.94M |
| Selling and administrative expenses | -9.83%61.06M | -20.79%61.89M | -9.46%62.55M | 3.66%275.93M | -9.62%61M | 6.55%67.71M | 7.83%78.14M | 10.23%69.08M | 26.59%266.18M | 8.69%67.49M |
| -Selling and marketing expense | -10.12%27.62M | -29.18%30.48M | -12.96%33.68M | -9.73%144.5M | -17.93%32.03M | -22.72%30.73M | -4.10%43.04M | 6.30%38.7M | 43.46%160.08M | 5.31%39.02M |
| -General and administrative expense | -9.58%33.44M | -10.51%31.41M | -5.00%28.86M | 23.88%131.43M | 1.77%28.98M | 55.49%36.98M | 27.24%35.1M | 15.68%30.38M | 7.51%106.1M | 13.68%28.47M |
| Research and development costs | -39.75%1.11M | -59.77%1.16M | 20.16%2.81M | 19.64%10.1M | 110.65%3.05M | -15.14%1.84M | 10.77%2.88M | 4.75%2.34M | 3.04%8.44M | -22.88%1.45M |
| Operating profit | 73.79%-21.52M | -68.20%-22.11M | 1.84%-16.99M | -406.63%-130.92M | -650.00%-18.36M | -1,786.08%-82.1M | -161.51%-13.15M | -23.53%-17.31M | 35.28%-25.84M | 76.69%-2.45M |
| Net non-operating interest income expense | -27.14%2.41M | -23.86%1.74M | 159.13%2.33M | 325.85%9.52M | 39.77%3.03M | 748.04%3.31M | 192.48%2.29M | 126.39%898K | 64.07%-4.22M | 162.92%2.17M |
| Non-operating interest income | -27.76%4.88M | -26.64%4.19M | 24.13%5.36M | 152.57%23.17M | 14.84%6.39M | 135.19%6.75M | 669.45%5.72M | --4.32M | 23,425.64%9.18M | --5.57M |
| Non-operating interest expense | -28.36%2.47M | -28.49%2.45M | -11.35%3.03M | 1.92%13.65M | -1.09%3.36M | 1.92%3.45M | 6.59%3.43M | 0.41%3.42M | 13.71%13.39M | -2.67%3.4M |
| Other net income (expense) | -67.32%2.76M | 68.08%20.22M | 277.47%13.33M | -74.13%19.5M | 7.78%6.53M | 113.51%8.46M | -13.42%12.03M | -114.58%-7.51M | 122.92%75.4M | 208.39%6.06M |
| Gain on sale of security | -24.83%2.7M | -75.81%2.9M | 65.17%-2.76M | -81.43%14.3M | -9.04%6.66M | -17.05%3.59M | -7.68%11.98M | -115.12%-7.93M | 123.74%77.05M | 113.96%7.33M |
| Other non- operating income (expenses) | -98.58%69K | 36,748.94%17.32M | 3,748.56%16.09M | 415.15%5.2M | 89.21%-137K | 1,449.58%4.87M | -94.86%47K | 144.75%418K | 63.24%-1.65M | -102.71%-1.27M |
| Income before tax | 76.77%-16.34M | -112.89%-151K | 94.41%-1.34M | -324.73%-101.89M | -252.30%-8.8M | -7,698.12%-70.34M | -81.68%1.17M | -170.21%-23.92M | 111.91%45.34M | 129.57%5.78M |
| Income tax | -44.01%1.95M | 83.90%-353K | 82.00%-659K | -259.01%-1.77M | 179.87%603K | 523.75%3.48M | -2,985.53%-2.19M | -240.04%-3.66M | 159.47%1.12M | -152.80%-755K |
| Net income | 75.22%-18.29M | -94.00%202K | 96.65%-679K | -326.38%-100.12M | -243.93%-9.4M | -91,033.33%-73.82M | -46.75%3.36M | -164.41%-20.26M | 111.68%44.22M | 131.16%6.53M |
| Net income continuous Operations | 75.22%-18.29M | -94.00%202K | 96.65%-679K | -326.38%-100.12M | -243.93%-9.4M | -91,033.33%-73.82M | -46.75%3.36M | -164.41%-20.26M | 111.68%44.22M | 131.16%6.53M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 75.22%-18.29M | -94.00%202K | 96.65%-679K | -326.38%-100.12M | -243.93%-9.4M | -91,033.33%-73.82M | -46.75%3.36M | -164.41%-20.26M | 111.68%44.22M | 131.16%6.53M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 75.22%-18.29M | -94.00%202K | 96.65%-679K | -326.38%-100.12M | -243.93%-9.4M | -91,033.33%-73.82M | -46.75%3.36M | -164.41%-20.26M | 111.68%44.22M | 131.16%6.53M |
| Basic earnings per share | 73.21%-0.15 | -94.56%0.0016 | 93.33%-0.01 | -353.33%-0.76 | -366.67%-0.08 | -104,183.05%-0.56 | -25.00%0.03 | -171.43%-0.15 | 108.09%0.3 | 125.00%0.03 |
| Diluted earnings per share | 73.21%-0.15 | -433.33%-0.1 | 33.33%-0.1 | -230.43%-0.76 | -366.67%-0.08 | -1,766.67%-0.56 | 150.00%0.03 | -15.38%-0.15 | 93.80%-0.23 | 125.00%0.03 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data